Literature DB >> 25816890

SENP1 regulates cell migration and invasion in neuroblastoma.

Yan Xiang-Ming1, Xu Zhi-Qiang2, Zhang Ting1, Wang Jian1, Pan Jian1, Yuan Li-Qun3, Fu Ming-Cui1, Xia Hong-Liang1, Cao Xu1, Zhou Yun1.   

Abstract

Neuroblastoma (NB) is an embryonic solid tumor derived from precursor cells of the sympathetic nervous system, and accounts for 11% of childhood cancers and around 15% of cancer deaths in children. SUMOylation and deSUMOylation are dynamic mechanisms regulating a spectrum of protein activities. The SUMO proteases (SENP) remove SUMO conjugate from proteins, and their expression is deregulated in diverse cancers. However, nothing is known about the role of SENPs in NBL. In the present study, we found that SENP1 expression was significantly high in metastatic NB tissues compared with primary NB tissues. Overexpression of SENP1 promoted NB cells migration and invasion. Inhibition of SENP1 could significantly suppress NB cell migration and invasion. Moreover, we found that SENP1 could regulate the expression of CDH1, MMP9, and MMP2. In summary, the data presented here indicate a significant role of SENP1 in the regulation of cell migration and invasion in NB and suppress SENP1 expression as promising candidates for novel treatment strategies of NB.
© 2015 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CDH1; SENP1; migration and invasion; neuroblastoma

Mesh:

Substances:

Year:  2015        PMID: 25816890     DOI: 10.1002/bab.1375

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  12 in total

Review 1.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

Review 2.  SENP Proteases as Potential Targets for Cancer Therapy.

Authors:  Paulina Tokarz; Katarzyna Woźniak
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

3.  Src SUMOylation Inhibits Tumor Growth Via Decreasing FAK Y925 Phosphorylation.

Authors:  Jing Wang; Rong Deng; Nan Cui; Hailong Zhang; Tianqi Liu; Jinzhuo Dou; Xian Zhao; Ran Chen; Yanli Wang; Jianxiu Yu; Jian Huang
Journal:  Neoplasia       Date:  2017-10-22       Impact factor: 5.715

4.  SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis.

Authors:  Baijun Dong; Yujing Gao; Xunlei Kang; Hongchang Gao; Jin Zhang; Hua Guo; Mingjian J You; Wei Xue; Jinke Cheng; Yiran Huang
Journal:  Oncotarget       Date:  2016-12-06

5.  The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis.

Authors:  Che-Chang Chang; Yen-Sung Huang; Ying-Mei Lin; Chia-Ju Lin; Jen-Chong Jeng; Shin-Mei Liu; Tsai-Ling Ho; Ruei-Ting Chang; Chun A Changou; Chun-Chen Ho; Hsiu-Ming Shih
Journal:  Sci Rep       Date:  2018-06-28       Impact factor: 4.379

6.  Ginsenoside Rk1 Induces Apoptosis in Neuroblastoma Cells Through Loss of Mitochondrial Membrane Potential and Activation of Caspases.

Authors:  Jung-Mi Oh; Jeongwoo Lee; Wan-Taek Im; Sungkun Chun
Journal:  Int J Mol Sci       Date:  2019-03-11       Impact factor: 5.923

Review 7.  The Function of SUMOylation and Its Role in the Development of Cancer Cells under Stress Conditions: A Systematic Review.

Authors:  Qi Zhao; Ying Ma; Zugui Li; Kexin Zhang; Minying Zheng; Shiwu Zhang
Journal:  Stem Cells Int       Date:  2020-11-13       Impact factor: 5.443

8.  SENP1 is required for the growth, migration, and survival of human adipose-derived stem cells.

Authors:  Yingying Wu; Beixin Yu; Min Wang
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

9.  CYLD and SUMO in neuroblastoma therapy.

Authors:  Katarzyna Chmielarska Masoumi; Ramin Massoumi
Journal:  Oncoscience       Date:  2016-01-29

10.  Engineering protein-protein devices for multilayered regulation of mRNA translation using orthogonal proteases in mammalian cells.

Authors:  Federica Cella; Liliana Wroblewska; Ron Weiss; Velia Siciliano
Journal:  Nat Commun       Date:  2018-10-22       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.